Use este identificador para citar ou linkar para este item:
https://www.arca.fiocruz.br/handle/icict/58309
Tipo de documento
ArtigoDireito Autoral
Acesso restrito
Data de embargo
2075-12-31
Coleções
Metadata
Mostrar registro completo
COVID-19 IN PATIENTS WITH CHRONIC KIDNEY DISEASE: A 2-YEAR STUDY OF INCIDENCE AND MORTALITY IN RELATION TO THE VARIANTS OF CONCERN WAVES IN BRAZIL
COVID-19
COVID-19 vaccines
mortality
SARS-CoV-2
variants of concern
Autor(es)
Afiliação
Diagnosis and Therapy of Infectious Diseases and Cancer. Rene Rachou Institute. Oswaldo Cruz Foundation. Belo Horizonte, MG, Brazil/Department of Infectious Diseases. College of Veterinary Medicine. University of Georgia. Athens, Georgia, USA
Diagnosis and Therapy of Infectious Diseases and Cancer. Rene Rachou Institute. Oswaldo Cruz Foundation. Belo Horizonte, MG, Brazil/Institute of Biological Sciences. Federal University of Minas Gerais. Belo Horizonte, MGerais, Brazil
Hospital da Baleia. Benjamin Guimarães Foundation. Belo Horizonte, MG, Brazil
Hospital da Baleia. Benjamin Guimarães Foundation. Belo Horizonte, MG, Brazil
Diagnosis and Therapy of Infectious Diseases and Cancer. Rene Rachou Institute. Oswaldo Cruz Foundation. Belo Horizonte, MG, Brazil
Diagnosis and Therapy of Infectious Diseases and Cancer. Rene Rachou Institute. Oswaldo Cruz Foundation. Belo Horizonte, MG, Brazil
Diagnosis and Therapy of Infectious Diseases and Cancer. Rene Rachou Institute. Oswaldo Cruz Foundation. Belo Horizonte, MG, Brazil
Hospital da Baleia. Benjamin Guimarães Foundation. Belo Horizonte, MG, Brazil
Diagnosis and Therapy of Infectious Diseases and Cancer. Rene Rachou Institute. Oswaldo Cruz Foundation. Belo Horizonte, MG, Brazil/Department of Infectious Diseases. College of Veterinary Medicine. University of Georgia. Athens, Georgia, USA/Institute of Biological Sciences. Federal University of Minas Gerais. Belo Horizonte, MG, Brazil
Diagnosis and Therapy of Infectious Diseases and Cancer. Rene Rachou Institute. Oswaldo Cruz Foundation. Belo Horizonte, MG, Brazil/Institute of Biological Sciences. Federal University of Minas Gerais. Belo Horizonte, MGerais, Brazil
Hospital da Baleia. Benjamin Guimarães Foundation. Belo Horizonte, MG, Brazil
Hospital da Baleia. Benjamin Guimarães Foundation. Belo Horizonte, MG, Brazil
Diagnosis and Therapy of Infectious Diseases and Cancer. Rene Rachou Institute. Oswaldo Cruz Foundation. Belo Horizonte, MG, Brazil
Diagnosis and Therapy of Infectious Diseases and Cancer. Rene Rachou Institute. Oswaldo Cruz Foundation. Belo Horizonte, MG, Brazil
Diagnosis and Therapy of Infectious Diseases and Cancer. Rene Rachou Institute. Oswaldo Cruz Foundation. Belo Horizonte, MG, Brazil
Hospital da Baleia. Benjamin Guimarães Foundation. Belo Horizonte, MG, Brazil
Diagnosis and Therapy of Infectious Diseases and Cancer. Rene Rachou Institute. Oswaldo Cruz Foundation. Belo Horizonte, MG, Brazil/Department of Infectious Diseases. College of Veterinary Medicine. University of Georgia. Athens, Georgia, USA/Institute of Biological Sciences. Federal University of Minas Gerais. Belo Horizonte, MG, Brazil
Resumo em Inglês
Background: Chronic kidney disease (CKD) is a risk factor for severe coronavirus disease (COVID-19). In Brazil, the disease is the 10th highest cause of death. We evaluated the epidemiological impact of COVID-19 in CDK and non-CDK patients.
Methods: Positive patients for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from 2020 to 2022 were classified according to the severity of COVID-19 and the numbers of cases and deaths were correlated to each wave of SARS-CoV-2 variants in Brazil.
Results: We compared all variables, and our data show that CDK significantly increased the mortality rate among patients, especially before COVID-19 vaccination, in comparison with non-CKD patients.
Conclusions: CKD patients had a significantly increased mortality rate compared with non-CKD
Palavras-chave em inglês
chronic kidney diseaseCOVID-19
COVID-19 vaccines
mortality
SARS-CoV-2
variants of concern
Compartilhar